Aspro Charl Verwey

Charl Verwey is a South African clinician-researcher in paediatric pulmonology, closely associated with respiratory research in Johannesburg and national surveillance platforms. His work centres on childhood lung disease in high HIV and tuberculosis burden settings, with a strong focus on respiratory syncytial virus, bronchiectasis, primary ciliary dyskinesia, and airway foreign body aspiration. He also contributes to global lung health initiatives and collaborative networks.

His publications highlight expertise in viral epidemiology and genomic surveillance, including influential studies on RSV evolution and coinfection with SARS-CoV-2, as well as landmark analyses of pneumococcal conjugate vaccine impact in South Africa. He advances lung function science through work with the Global Lung Function Initiative and feasibility studies of infant pulmonary testing in low-resource contexts, strengthening diagnostic capacity and standardisation.

Additional contributions address antimicrobial resistance in chronic respiratory disease and the rational use of systemic corticosteroids, reflecting commitment to stewardship and evidence-based care. Across clinical, laboratory, and population-level research, his scholarship informs policy, improves diagnostic pathways, and supports vaccine and prevention strategies tailored to low- and middle-income countries.